Life Science Compliance Update

In the Media

  • "A report by Tom Sullivan in “Life Science Compliance Update” finds that research payments to HCPs fell from $1.55 billion during the last 5 months of 2013 (all that was collected that year) to $1.06 billion during the same period in 2014 – a 32% drop. Meanwhile, there were only slight changes in transfers of value for other categories – food, consulting fees, travel."


  • "But now a study has shown research spending may be down as a result of the act. The August issue of Life Science Compliance Update, published by Policy & Medicine, notes an analysis conducted on the U.S. government’s Open Payments database shows U.S.-based clinical research has fallen by 32 percent in a year-over-year comparison, the first since Open Payments data started being collected. "


  • “Although this is only a partial year comparison, it suggests a disturbing trend that we will want to watch closely moving forward,” said Thomas Sullivan, Editor of Life Science Compliance Update. “A decline in domestic research would be an unfortunate unintended consequence of transparency.”


  • "Per Life Science Compliance Update, an analysis of the Centers for Medicare and Medicaid Services (CMS) Open Payments database reveals that drug and device manufacturers spent about $1.5 billion in research payments between August 2013 and December 2013. "


  • "Could the Sunshine Act be creating an unintentional downward trend in clinical research? An analysis of the U.S. government's Open Payments database shows that industry spending on U.S-based clinical research has dropped 32 percent in the first year-over-year comparison since Open Payments data started to be collected. The results are published in the August issue of Life Science Compliance Update, a monthly newsletter published by Policy & Medicine."


  • "Although this is only a partial year comparison, it suggests a disturbing trend that we will want to watch closely moving forward," said Thomas Sullivan, Editor, Life Science Compliance Update. "A decline in domestic research would be an unfortunate unintended consequence of transparency." Written by Life Science Compliance Update authors Sullivan and Matthew Chandler, the new article cites that manufacturers were generally consistent in their payments for the two time periods.


  • "USA-based clinical research spending has dropped 32% in the first year-on-year comparison since Open…"


  • "New analysis of the U.S. government's Open Payments database, published in the August issue of Life Science Compliance Update, shows that industry spending on U.S-based clinical research dropped by 32 percent in the first year-over-year comparison since Open Payments data started to be collected."


  • "Industry spending on clinical research fell 32% in the last five months of 2014, compared to the same period a year, according to Policy & Medicine's Life Science Compliance Update, which analyzed Open Payments data. The CMS in June released the first full year of Open Payments data, which is mandated by the Physician Payments Sunshine Act."


  • "Medical education company Rockpointe launched Life Science Compliance Update, an online publication meant to explore and discuss regulatory issues in healthcare. The magazine was created by the publishers of Policy & Medicine."

Gravityscan Badge
Menu Title